Health Economics Policy and Law

Papers
(The TQCC of Health Economics Policy and Law is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Australia's Response to COVID-1979
Response to COVID-19: was Italy (un)prepared?44
France's response to the Covid-19 pandemic: between a rock and a hard place29
United States response to the COVID-19 pandemic, January–November 202024
Unmasking a health care system: the Dutch policy response to the Covid-19 crisis21
Need, demand, supply in health care: working definitions, and their implications for defining access21
Going hard and early: Aotearoa New Zealand's response to Covid-1918
The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’11
Ireland's takeover of private hospitals during the COVID-19 pandemic11
Soft law and individual responsibility: a review of the Swedish policy response to COVID-1911
Changes in the balance between formal and informal care supply in England between 2001 and 2011: evidence from census data10
Health economics and emergence from COVID-19 lockdown: the great big marginal analysis10
Neither protective nor harmonized: the crossborder regulation of medical devices in the EU10
Evolution of the determinants of unmet health care needs in a universal health care system: Canada, 2001–20149
Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?9
Alternative provision of public health care: the role of citizens' satisfaction with public services and the social responsibility of government9
Belgium's response to the COVID-19 pandemic7
World-beating? Testing Britain's Covid response and tracing the explanation7
Understanding public procurement within the health sector: a priority in a post-COVID-19 world7
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention7
Necessity under construction – societal weighing rationality in the appraisal of health care technologies7
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times7
Health, federalism and the European Union: lessons from comparative federalism about the European Union7
State strategies to address medicaid prescription spending: negotiated pricing vs price transparency6
A tribute to the foot soldiers: European health agencies in the fight against antimicrobial resistance6
Resilient managed competition during pandemics: lessons from the Italian experience during COVID-196
Expanding health care coverage in Canada: a dramatic shift in the debate6
Do patients benefit from legislation regulating step therapy?6
An application of PCA-DEA with the double-bootstrap approach to estimate the technical efficiency of New Zealand District Health Boards6
Assessing the potential impact on health of the UK's future relationship agreement with the EU: analysis of the negotiating positions5
Learning from health system reform trajectories in seven Canadian provinces5
Strengthening health system governance in Germany: looking back, planning ahead5
Learning lessons from the COVID-19 pandemic4
Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies4
Physician behaviour, malpractice risk and defensive medicine: an investigation of cesarean deliveries4
Preserving social equity in marketized primary care: strategies in Sweden4
(Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time4
0.023730039596558